A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

NCT ID: NCT06221969

Last Updated: 2025-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-16

Study Completion Date

2026-04-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide that doctors may prescribe in some countries. Participants will get either CagriSema or tirzepatide. Which treatment participant get is decided by chance like flipping a coin. Participant will have an equal chance of receiving either drug. For each participant, the study will last for up to one and a half years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CagriSema

Participants will receive cagrilintide dose 1 and semaglutide dose 2 subcutaneously once-weekly (dose escalation period of 16 weeks) for up to 68 weeks.

Group Type EXPERIMENTAL

Cagrilintide

Intervention Type DRUG

Cagrilintide will be administered subcutaneously.

Semaglutide

Intervention Type DRUG

Semaglutide will be administered subcutaneously.

Tirzepatide

Participants will receive tirzepatide dose 1 subcutaneously once-weekly (dose escalation period of 20 weeks) for up to 68 weeks.

Group Type ACTIVE_COMPARATOR

Tirzepatide

Intervention Type DRUG

Tirzepatide will be administered subcutaneously.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cagrilintide

Cagrilintide will be administered subcutaneously.

Intervention Type DRUG

Semaglutide

Semaglutide will be administered subcutaneously.

Intervention Type DRUG

Tirzepatide

Tirzepatide will be administered subcutaneously.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female (sex at birth).
* Age 18 years or above at the time of signing the informed consent.
* Diagnosed with type 2 diabetes ≥ 180 days before screening.
* Stable daily dose(s) ≥ 90 days before screening of any of the following antidiabetic drug(s) or combination regimen(s) at effective or maximum tolerated dose as judged by the investigator: metformin with or without an sodium-glucose co-transporter-2 (SGLT2) inhibitor.
* HbA1c 7.0-10.5% (53-91 mmol/mol) (both inclusive) as determined by central laboratory at screening.
* Body mass index (BMI) of ≥ 30.0 kilogram per square meter (kg/m\^2) at screening. BMI will be calculated in the electronic case report form (eCRF) based on height and body weight at screening.

* Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by an eye examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination.

Exclusion Criteria

* Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using a highly effective contraceptive method.
* Renal impairment with estimated Glomerular Filtration Rate \< 30 milliliter per minute per 1.73 square meter (mL/min/1.73 m\^2) as determined by central laboratory at screening.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novo Nordisk A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Transparency (dept. 2834)

Role: STUDY_DIRECTOR

Novo Nordisk A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Synexus Clin Res-Birmingham

Birmingham, Alabama, United States

Site Status

Univ of Alabama_Birmingham

Birmingham, Alabama, United States

Site Status

Prime Medical Group, LLC

Gilbert, Arizona, United States

Site Status

Velocity Clinical Research-Phoenix

Phoenix, Arizona, United States

Site Status

Synexus Rsch /Cnt Phnx Med C

Phoenix, Arizona, United States

Site Status

Arkansas Clinical Research

Little Rock, Arkansas, United States

Site Status

Unity Health-Searcy Medical Center

Searcy, Arkansas, United States

Site Status

Velocity Clin Res-Chula Vista

Chula Vista, California, United States

Site Status

Headlands Research California, LLC

Escondido, California, United States

Site Status

Neighborhood Healthcare

Escondido, California, United States

Site Status

St. Jude Heritage Yorba Linda - Pediatric Ste D

Fullerton, California, United States

Site Status

Diabetes & Endocrine Specialists - La Mesa

La Mesa, California, United States

Site Status

Diabetes and Endocrine Specialists - La Mesa

La Mesa, California, United States

Site Status

Velocity Clin Res San Diego

La Mesa, California, United States

Site Status

Clinical Trials Research

Lincoln, California, United States

Site Status

Loma Linda Univ Hlth Cr Endo

Loma Linda, California, United States

Site Status

Valley Clinical Trials, Inc.

Northridge, California, United States

Site Status

Desert Oasis Healthcare

Palm Springs, California, United States

Site Status

Velocity Clin Res - Panorama

Panorama City, California, United States

Site Status

Western University of Health Sciences

Pomona, California, United States

Site Status

Endocrinology Josel Cabaccan

San Jose, California, United States

Site Status

Mills-Peninsula Medical Center

San Mateo, California, United States

Site Status

NorCal Endocrinology and Internal Medicine

San Ramon, California, United States

Site Status

Premier Medical Center, Inc.

Toluca Lake, California, United States

Site Status

Velocity Clin Res - Panorama

Van Nuys, California, United States

Site Status

Diablo Clinical Research, Inc.

Walnut Creek, California, United States

Site Status

University of Colorado Hospital

Aurora, Colorado, United States

Site Status

Optumcare Clinical Trials,LLC-Golden

Colorado Springs, Colorado, United States

Site Status

Northeast Res Inst. Inc.

Jacksonville, Florida, United States

Site Status

Clinical Trial Services Corp

Miami, Florida, United States

Site Status

Bioclinical Research Alliance

Miami, Florida, United States

Site Status

New Horizon Research Center

Miami, Florida, United States

Site Status

South Broward Research LLC

Miramar, Florida, United States

Site Status

West Orange Endocrinology

Ocoee, Florida, United States

Site Status

Optimal Research Sites

Orange City, Florida, United States

Site Status

Trans Res Inst for Met & Diab

Orlando, Florida, United States

Site Status

Oviedo Medical Research, LLC

Oviedo, Florida, United States

Site Status

Hope Clin Res & Wellness

Conyers, Georgia, United States

Site Status

Center for Adv Res & Education

Gainesville, Georgia, United States

Site Status

Urban Family Practice Assoc

Marietta, Georgia, United States

Site Status

Endocrine Research Solutions

Roswell, Georgia, United States

Site Status

Pacific Diabetes & Endo Ctr

Honolulu, Hawaii, United States

Site Status

St. Luke's Health System

Boise, Idaho, United States

Site Status

Solaris Clinical Research

Meridian, Idaho, United States

Site Status

Cedar-Crosse Research Center

Chicago, Illinois, United States

Site Status

Clinical Invest Special_Gurnee

Gurnee, Illinois, United States

Site Status

Endeavor Health

Skokie, Illinois, United States

Site Status

Evanston Premier Hlthcr Res

Skokie, Illinois, United States

Site Status

American Health Network of Indiana, LLC_Greenfield

Greenfield, Indiana, United States

Site Status

Iowa Diabetes & Endo Res Ctr

West Des Moines, Iowa, United States

Site Status

Cotton-O'Neil Diab & Endo Ctr

Topeka, Kansas, United States

Site Status

Velocity Clin Res Lafayette

Lafayette, Louisiana, United States

Site Status

MedStar Hlth Res Institute

Hyattsville, Maryland, United States

Site Status

Joslin Diabetes Center

Boston, Massachusetts, United States

Site Status

International Diabetes Center

Minneapolis, Minnesota, United States

Site Status

Belzoni Clinical Research

Belzoni, Mississippi, United States

Site Status

Velocity Clin Res Gulfport

Gulfport, Mississippi, United States

Site Status

Diabetes & Endo Specialists Inc

Chesterfield, Missouri, United States

Site Status

StudyMetrix Research LLC

City of Saint Peters, Missouri, United States

Site Status

Amicis Centers of Clinical Research

St Louis, Missouri, United States

Site Status

Velocity Clin Res Albuquerque

Albuquerque, New Mexico, United States

Site Status

AMC Community Endocrinology

Albany, New York, United States

Site Status

Velocity Clin Res Syracuse

East Syracuse, New York, United States

Site Status

Southgate Medical Group, LLP

West Seneca, New York, United States

Site Status

UNC Eastowne Clinical Research Unit

Chapel Hill, North Carolina, United States

Site Status

PharmQuest Life Sciences LLC

Greensboro, North Carolina, United States

Site Status

Carteret Medical Group

Morehead City, North Carolina, United States

Site Status

Lucas Research Inc.

Morehead City, North Carolina, United States

Site Status

Piedmont Healthcare/Research

Statesville, North Carolina, United States

Site Status

Accellacare

Wilmington, North Carolina, United States

Site Status

Plains Clinical Research Center, LLC

Fargo, North Dakota, United States

Site Status

Remington Davis Inc

Columbus, Ohio, United States

Site Status

Advanced Medical Research

Maumee, Ohio, United States

Site Status

New Venture Medical Research

Wadsworth, Ohio, United States

Site Status

Lynn Institute of Norman

Norman, Oklahoma, United States

Site Status

CCT Research

Horsham, Pennsylvania, United States

Site Status

Thomas Jefferson University_Philadelphia

Philadelphia, Pennsylvania, United States

Site Status

Clinical Res Collaborative

Cumberland, Rhode Island, United States

Site Status

Velocity Clin Res Providence

East Greenwich, Rhode Island, United States

Site Status

Velocity Clinical Res-Anderson

Anderson, South Carolina, United States

Site Status

Trial Management Associates

Myrtle Beach, South Carolina, United States

Site Status

Hillcrest Clinical Research

Simpsonville, South Carolina, United States

Site Status

Spartanburg Medical Research

Spartanburg, South Carolina, United States

Site Status

AM Diabetes And Endocrinology Center

Bartlett, Tennessee, United States

Site Status

Holston Medical Group Pc

Bristol, Tennessee, United States

Site Status

Univ Diab & Endo Consultants

Chattanooga, Tennessee, United States

Site Status

Jackson Clinic

Jackson, Tennessee, United States

Site Status

Holston Medical Group

Kingsport, Tennessee, United States

Site Status

Clinical Neuroscience Solutions

Memphis, Tennessee, United States

Site Status

HealthStar Physicians PC

Morristown, Tennessee, United States

Site Status

Clinical Research Associates

Nashville, Tennessee, United States

Site Status

Arlington Family Res. Ctr Inc

Arlington, Texas, United States

Site Status

Velocity Clin Res

Austin, Texas, United States

Site Status

UT Health University of Texas

Bellaire, Texas, United States

Site Status

Velocity Clin Res, Dallas

Dallas, Texas, United States

Site Status

North Texas Endocrine Center

Dallas, Texas, United States

Site Status

Synexus Clin Res Dallas

Dallas, Texas, United States

Site Status

Cedar Health Research

Dallas, Texas, United States

Site Status

PrimeCare Medical Group

Houston, Texas, United States

Site Status

JCCT- Juno NW Houston

Houston, Texas, United States

Site Status

Discovery MM Services, Inc

Houston, Texas, United States

Site Status

PlanIt Research, PLLC

Houston, Texas, United States

Site Status

Amir Ali Hassan, MD, PA

Houston, Texas, United States

Site Status

Fmc Science, Llc

Lampasas, Texas, United States

Site Status

Quality Clinical Research, Inc.

San Antonio, Texas, United States

Site Status

University of Texas San Antonio

San Antonio, Texas, United States

Site Status

NE Clin Res of San Antonio

San Antonio, Texas, United States

Site Status

University of Texas San Antonio

San Antonio, Texas, United States

Site Status

Consano Clinical Research, LLC

Shavano Park, Texas, United States

Site Status

Mt Olympus Medical Research, LLC

Sugar Land, Texas, United States

Site Status

DM Clin Rsrch/Fam Diag Clinic

Tomball, Texas, United States

Site Status

Foothill Family Clinic South

Salt Lake City, Utah, United States

Site Status

J.Lewis Research Inc

South Jordan, Utah, United States

Site Status

Velocity Clin Res-Salt Lk City

West Jordan, Utah, United States

Site Status

TPMG Clinical Research

Newport News, Virginia, United States

Site Status

Rainier Clin Res Ctr Inc

Renton, Washington, United States

Site Status

Prevea Health

Green Bay, Wisconsin, United States

Site Status

Buenos Aires Mácula

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

CICEMO- Consultorio de Investigación Clínica EMO

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Instituto Medico Especializado_Capital Federal

Ciudad de Buenos Aires, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Metabolicas (IDIM)

Buenos Aires, , Argentina

Site Status

OMI- Organización Médica de Investigación

Buenos Aires, , Argentina

Site Status

CICEMO- Consultorio de Investigación Clínica EMO

Buenos Aires, , Argentina

Site Status

CEDIC Centro de Investigación Clínica

CABA, , Argentina

Site Status

Centro de Investigación Clínica

CABA, , Argentina

Site Status

Instituto de Investigaciones Clinicas Mar Del Plata

Mar del Plata, , Argentina

Site Status

CEDIR - Centro de diagnóstico y rehabilitación Santa Fe

Santa Fe, , Argentina

Site Status

Paratus Clinical

Blacktown, New South Wales, Australia

Site Status

Paratus Clinical

Kanwal, New South Wales, Australia

Site Status

Hunter Diabetes Centre

Merewether, New South Wales, Australia

Site Status

Royal North Shore Hospital

St Leonards, New South Wales, Australia

Site Status

Townsville University Hospital

Douglas, Queensland, Australia

Site Status

University of Sunshine Coast

Morayfield, Queensland, Australia

Site Status

Momentum Clinical Research

Taringa, Queensland, Australia

Site Status

Southern Adelaide Diabetes & Endocrine Services

Oaklands Park, South Australia, Australia

Site Status

The Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Austrials

St Albans, Victoria, Australia

Site Status

Momentum Clinical Research

St Albans, Victoria, Australia

Site Status

Centricity Research Calgary Endocrinology

Calgary, Alberta, Canada

Site Status

Guilford Med Clinic

Surrey, British Columbia, Canada

Site Status

TLC Diabetes and Endocrinology

Surrey, British Columbia, Canada

Site Status

Ocean West Research Clinic

Surrey, British Columbia, Canada

Site Status

Hilltop Medical Clinic

Surrey, British Columbia, Canada

Site Status

G.A. Research Associates Ltd.

Moncton, New Brunswick, Canada

Site Status

Centricity Research Brampton Endocrinology

Brampton, Ontario, Canada

Site Status

Milestone Research

London, Ontario, Canada

Site Status

Western Univ. Cnt for Studies in Fam Med

London, Ontario, Canada

Site Status

London Road Diagnostic Clinic and Medical Centre

Sarnia, Ontario, Canada

Site Status

Centricity Research Toronto

Toronto, Ontario, Canada

Site Status

Diabetes Heart Research Centre

Toronto, Ontario, Canada

Site Status

Centre Medical Acadie

Montreal, Quebec, Canada

Site Status

ALPHA Recherche Clinique

Québec, Quebec, Canada

Site Status

Ctr de Med Metab de Lanaudiere

Terrebonne, Quebec, Canada

Site Status

Diex Recherche Victoriaville

Victoriaville, Quebec, Canada

Site Status

Centricity Research Oshawa

Barrie, West Oshawa, Canada

Site Status

Clin des Mal Lipid de Quebec

Québec, , Canada

Site Status

Centre de Recherche Saint-Louis

Québec, , Canada

Site Status

Clinica de la Costa

Barranquilla, Atlántico, Colombia

Site Status

FOSCAL

Floridablanca, Santander Department, Colombia

Site Status

Cimedical

Barranquilla, , Colombia

Site Status

Centro de Investigación en Reumatología y Especialidades Médicas S.A.S. CIREEM S.A.S.

Bogotá, , Colombia

Site Status

UNIENDO

Bogotá, , Colombia

Site Status

Nirmal Hospital Pvt. Ltd.

Surat, Gujarat, India

Site Status

SSG Hospital, Baroda

Vadodara, Gujarat, India

Site Status

Belgaum Diabetes Centre

Belagavi, Karnataka, India

Site Status

Government Medical College, Kozhikode

Kozhikode, Kerala, India

Site Status

Indian Institute of Diabetes

Thiruvnanthapuram, Kerala, India

Site Status

Seth GS Medical College & KEM Hospital

Mumbai, Maharashtra, India

Site Status

BSES MG hospital

Mumbai, Maharashtra, India

Site Status

Grant Medical Foundation Ruby Hall Clinic

Pune, Maharashtra, India

Site Status

Chellaram Diabetes Institute

Pune, Maharashtra, India

Site Status

Maulana Azad Medical College

Delhi, New Delhi, India

Site Status

SMS Medical College & Hospital

Jaipur, Rajasthan, India

Site Status

Diabetes, Thyroid and Endocrine Centre

Jaipur, Rajasthan, India

Site Status

Christian Medical College Hospital, Vellore

Vellore, Tamil Nadu, India

Site Status

AIG Hospitals,Hyderabad

Hyderabad, Telangana, India

Site Status

Government Institute of Medical Sciences

Noida, Uttar Pradesh, India

Site Status

BP Poddar Hospital

Kolkata, West Bengal, India

Site Status

Rajiv Gandhi Centre for Diabetes and Endocrinology, J.N Medical College, Aligarh Muslim University

Aligarh, , India

Site Status

SRM Centre for Clinical Trials & Research

Chennai, , India

Site Status

Nirmal Hospital Pvt. Ltd.

Surat, , India

Site Status

Jothydev's Diabetes & Research Center

Thriruvananthapuram, , India

Site Status

Dr Wilhase's rooms

Boksburg, Gauteng, South Africa

Site Status

Ubuntu Clinical Research

Johannesburg, Gauteng, South Africa

Site Status

Krugersdorp Medical Centre

Krugersdorp, Gauteng, South Africa

Site Status

Synapta Clinical Research Centre

Durban, KwaZulu-Natal, South Africa

Site Status

Dr J Reddy

Durban, KwaZulu-Natal, South Africa

Site Status

Bella Vita Clinical Research

Cape Town, Western Cape, South Africa

Site Status

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

Chung Shan Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

Kuang Tien General Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

National Taiwan University Hospital_main

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Canada Colombia India South Africa Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1282-5561

Identifier Type: OTHER

Identifier Source: secondary_id

2023-503789-21-00

Identifier Type: OTHER

Identifier Source: secondary_id

NN9388-4894

Identifier Type: -

Identifier Source: org_study_id